Web Analytics

3 Latest Announced Rounds

  • $10,600,000
    Pre-Seed

    5 Investors

    Technology, Information and Internet
    Jun 6th, 2025
  • $13,702,071
    Series A

    3 Investors

    Insurance
    Jun 6th, 2025
  • $15,000,000
    Unknown

    1 Investors

    Biotechnology Research
    Jun 6th, 2025
$863.23M Raised in 46 Funding Rounds in the past 7 Days - View All

Funding Round Profile

LyGenesis

start up
United States - Pittsburgh, Pennsylvania
  • 25/10/2023
  • Pre Series A
  • $19,000,000

LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. LyGenesis’ lead preclinical program is focused on liver regeneration for patients with end stage liver disease. Other therapeutic targets for organ regeneration include the thymus, pancreas, and kidney. Privately held, LyGenesis is headquartered in Pittsburgh, Pennsylvania. To learn more, please visit our website at www.lygenesis.com.


Related People

Michael HuffordCo Founder

Michael Hufford United States - Pittsburgh, Pennsylvania

N/A